Ugoos X5M Pro is a TV box based on Amlogic S905X5M chipset, which is one of the new budget chipsets from Amlogic (no VCC/H.266 support for instance). This box is similar if not identical to it’s older brothers from X4 family (reviewed here in the past), and the specs are simply upgraded. Aside for BT …
Ugoos AM9 is Ugoos’ newest offering, but like with SK series (SK1 to SK2), it takes a step back. From the powerful AM6 Pro and the AM8 (not sure where AM7 went), it goes to a cheaper chipset (Amlogic S905X5) with lighter specs. Many thanks goes to James from Ugoos for providing the AM9 Review …
Ugoos SK2 is Ugoos’ new budget Android TV box, and it’s a bit different than their other boxes. The biggest difference is the OS. SK2 uses Google Android TV at its core, and a realtek RTD1325 chipset. All of that is done to keep costs down, while still including licensing for the big streaming services. …
FIX 2026 recognized nine companies for innovations in humanoid robotics, autonomous vehicles, industrial AI, cybersecurity, and data center cooling. At FIX 2026 in Daegu, South Korea, nine companies presented their technologies at a press conference highlighting the winners of the Best Innovation Technology Awards, FIX 2026’s highest distinction. A panel of 26 judges selected the nine …
A hands-on guide with Gemma 4, Ollama, and the OpenAI Agents SDK The post How to Add Guardrails to a Local LLM Agent appeared first on Towards Data Science. Read More
Here’s what it finds that cProfile misses The post Python 3.15 Has a New Profiler appeared first on Towards Data Science. Read More
Editor in Chief Nancy Shute discusses the power of the human voice, hopeful advances in treating stiff person syndrome and new controversy about using AI in mathematics. Read More
Nature Medicine, Published online: 24 October 2026; doi:10.1038/s41591-026-04756-1 As presented at the ESMO Congress 2026: In a 5 year follow-up of survival and correlative data from the pivotal phase 3 RELATIVITY-047 trial comparing relatlimab plus nivolumab versus nivolumab alone in patients with metastatic or unresectable melanoma, statistically significant differences in progression-free survival, overall survival and …